Lawyers from MDDP Olkiewicz i Wspólnicy advised a start-up Nutrix in the process of obtaining venture capital funding under the NCBR program BRIdge Alfa. The CARLSON EVIG Alpha VC fund, which supports businesses at an early stage of development, decided to invest in this innovative company.
Nutrix is a Swiss-based medtech start-up specializing in the development of technologically advanced sensors for monitoring glucose levels in saliva. The Nutrix team is developing software to help treat diabetes through the use of artificial intelligence algorithms.
The project team was led by Tomasz Olkiewicz (attorney at law, managing partner of MDDP Olkiewicz i Wspólnicy) and supported by Aleksandra Cywińska (attorney at law) and Norbert Lutowski (legal assistant).